Regular slow wave flowmotion in skeletal muscle is not determined by nitric oxide and endothelin

Citation
D. Erni et al., Regular slow wave flowmotion in skeletal muscle is not determined by nitric oxide and endothelin, MICROVASC R, 58(2), 1999, pp. 167-176
Citations number
35
Categorie Soggetti
Cardiovascular & Hematology Research
Journal title
MICROVASCULAR RESEARCH
ISSN journal
00262862 → ACNP
Volume
58
Issue
2
Year of publication
1999
Pages
167 - 176
Database
ISI
SICI code
0026-2862(199909)58:2<167:RSWFIS>2.0.ZU;2-N
Abstract
In a previous study we showed that the generation of regular slow wave flow motion (rSWFM, 1-3 cycles per minute) in skeletal muscle of anesthetized ra ts was related to local changes of arterial pressure and microcirculatory b lood flow (MBF), which suggests an involvement of pressure- or flow-induced mechanisms. The present experiments were designed to test the role of flow -dependent endothelial autacoids, such as nitric oxide (NO) and endothelin, in the generation of SWFM. The effects of NO-donor sodium nitroprusside (S NP), the partly NO-dependent metabolite adenosine (ADO), the NO-synthase in hibitor N-G-nitro-L-arginine methyl ester (L-NAME), and the mixed endotheli n receptor blocker bosentan (BOS) were analyzed. MBF and rSWFM were assesse d by laser Doppler flowmetry. rSWFM appeared in 7 out of 14 preparations af ter ADO (200 mu g/kg/min), but not after SNP (100 mu g/kg/min), L-NAME (30 mg/kg iv), and BOS (10 mg/kg iv). Its occurrence was associated with a sign ificant decrease in arterial pressure to 50 +/- 3% (mean +/- SEM) of the ba seline, provided that MBF was not enhanced. When given after induction of r SWFM by a 25% hemorrhage, SNP (50 mu g/kg/min) totally abolished rSWFM and ADO (100 mu g/kg/min) reduced rSWFM frequency from 2.17 +/- 0.08 to 1.72 +/ - 0.08 cycles per minute (cpm) (P < 0.05), whereas the frequency was not af fected by the other drugs. ADO, L-NAME (30 mg/kg iv), and BOS (10 mg/kg iv) lead to changes in rSWFM amplitude which showed a drug-independent negativ e correlation to changes in both MAP and MBF (R-2 = 0.61, multiple regressi on) in the ranges of 57-176% of MAP before drug application, and 72-120% of MBF, respectively. We conclude that NO and endothelin are not involved in the generation of rSWFM. Our findings strongly suggest that the activity of rSWFM depends on a reduction of vascular wall tension and is inhibited by SNP. (C) 1999 Academic Press.